Insider Trading Activity For Citius Pharmaceuticals Inc (NASDAQ:CTXR)
Leonard L Mazur , Major Shareholder of Citius Pharmaceuticals Inc (NASDAQ:CTXR) reportedly Bought 2,234,700 shares of the company’s stock at an average price of 0.9 for a total transaction amount of $2,011,230.00 SEC Form
Insider Trading History For Citius Pharmaceuticals Inc (NASDAQ:CTXR)
On 8/8/2017 Leonard L Mazur, Insider, bought 421,400 with an average share price of $4.13 per share and the total transaction amounting to $1,740,382.00.
On 8/24/2017 Leonard L Mazur, Insider, bought 11,000 with an average share price of $2.68 per share and the total transaction amounting to $29,480.00.
On 3/28/2018 Myron Z Holubiak, Insider, bought 2,915 with an average share price of $3.09 per share and the total transaction amounting to $9,007.35.
On 8/13/2018 Myron Z Holubiak, Insider, bought 784,314 with an average share price of $1.28 per share and the total transaction amounting to $1,003,921.92.
On 4/3/2019 Myron Z Holubiak, Insider, bought 129,450 with an average share price of $1.55 per share and the total transaction amounting to $200,647.50.
On 4/3/2019 Leonard L Mazur, Major Shareholder, bought 1,165,048 with an average share price of $1.55 per share and the total transaction amounting to $1,805,824.40.
On 9/27/2019 Myron Z Holubiak, CEO, bought 558,597 with an average share price of $0.90 per share and the total transaction amounting to $502,737.30.
Analyst Ratings History For Citius Pharmaceuticals Inc (NASDAQ:CTXR)
- On 2/7/2019 HC Wainwright Reiterated Rating Buy with a price target of $3.00
- On 9/6/2019 Dawson James Initiated Coverage of rating Buy with a price target of $7.00
Recent Trading Activity for Citius Pharmaceuticals Inc (NASDAQ:CTXR)
Shares of Citius Pharmaceuticals Inc closed the previous trading session at with 98652 shares trading hands.